Publikationen 2017

Fritsch K, Kasenda B, Schorb E, Hau P, Bloehdorn J, Möhle R, Löw S, Binder M, Atta J, Keller U, Wolf HH, Krause SW, Heß G, Naumann R, Sasse S, Hirt C, Lamprecht M, Martens U, Morgner A, Panse J, Frickhofen N, Röth A, Hader C, Deckert M, Fricker H, Ihorst G, Finke J, Illerhaus G:(2017)High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study).Leukemia. 2017;31(4): 846-852
Qorraj M, Bruns H, Böttcher M, Weigand L, Saul D, Mackensen A, Jitschin R, Mougiakakos D:(2017)The PD-1/PD-L1 axis contributes to immune metabolic dysfunctions of monocytes in chronic lymphocytic leukemia.Leukemia. 2017;31(2): 470-478
Koehler P, Hamprecht A, Bader O, Bekeredjian-Ding I, Buchheidt D, Doelken G, Elias J, Haase G, Hahn-Ast C, Karthaus M, Kekulé A, Keller P, Kiehl M, Krause SW, Krämer C, Neumann S, Rohde H, La Rosée P, Ruhnke M, Schafhausen P, Schalk E, Schulz K, Schwartz S, Silling G, Staib P, Ullmann A, Vergoulidou M, Weber T, Cornely OA, Vehreschild MJ:(2017)Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA Study.Int J Antimicrob Agents. 2017;49(2): 218-223
Hartwell MJ, Özbek U, Holler E, Renteria AS, Major-Monfried H, Reddy P, Aziz M, Hogan WJ, Ayuk F, Efebera YA, Hexner EO, Bunworasate U, Qayed M, Ordemann R, Wölfl M, Mielke S, Pawarode A, Chen YB, Devine S, Harris AC, Jagasia M, Kitko CL, Litzow MR, Kröger N, Locatelli F, Morales G, Nakamura R, Reshef R, Rösler W, Weber D, Wudhikarn K, Yanik GA, Levine JE, Ferrara JL:(2017)An early-biomarker algorithm predicts lethal graft-versus-host disease and survival.JCI Insight. 2017;2(3): e89798
Meintker L, Fritsch JD, Ringwald J, Krause SW:(2017)Immature platelets do not reliably predict platelet recovery in patients with intensive chemotherapy or stem cell transplantation.Vox Sang. 2017;112(2): 132-139
Müller MJ, Bruns H, Volmer DA:(2017)Direct aqueous measurement of 25-hydroxyvitamin D levels in a cellular environment by LC-MS/MS using the novel chemical derivatization reagent MDBP.Anal Bioanal Chem. 2017;409(10): 2705-2714
Bruns H, Böttcher M, Qorraj M, Fabri M, Jitschin S, Dindorf J, Busch L, Jitschin R, Mackensen A, Mougiakakos D:(2017)CLL-cell-mediated MDSC induction by exosomal miR-155 transfer is disrupted by vitamin D.Leukemia. 2017;31(4): 985-988
Einsele H, Knop S, Vogel M, Müller J, Kropff M, Metzner B, Langer C, Sayer H, Jung W, Dürk HA, Salwender H, Wandt H, Bassermann F, Gramatzki M, Rösler W, Wolf HH, Brugger W, Engelhardt M, Fischer T, Liebisch P, Straka C:(2017)Response-adapted consolidation with bortezomib after ASCT improves progression-free survival in newly diagnosed multiple myeloma.Leukemia. 2017;31(6): 1463-1466
Krebs AM, Mitschke J, Losada ML, Schmalhofer O, Boerries M, Busch H, Boettcher M, Mougiakakos D, Reichardt W, Bronsert P, Brunton VG, Pilarsky C, Winkler TH, Brabletz S, Stemmler MP, Brabletz T:(2017)The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer.Nat Cell Biol. 2017;19(5): 518-529
Cybulska A, Meintker L, Ringwald J, Krause SW:(2017)Measurements of immature platelets with haematology analysers are of limited value to separate immune thrombocytopenia from bone marrow failure.Br J Haematol. 2017;177(4): 612-619
Krause SW, Neubauer A:(2017)[Choosing wisely recommendations in hematology and oncology].Internist (Berl). 2017;58(6): 545-549
Knop S, Langer C, Engelhardt M, Mügge LO, Reichle A, Rösler W, Bassermann F, Hertenstein B, Kunitz A, Röllig C, Ostermann H, Schäfer-Eckart K, Ringhoffer M, Günther A, Junghanss C, Biersack H, Schreder M, Liebert A, Held S, Einsele H, Bargou RC:(2017)Lenalidomide, adriamycin, dexamethasone for induction followed by stem-cell transplant in newly diagnosed myeloma.Leukemia. 2017;31(8): 1816-1819
Müller F, Stookey S, Cunningham T, Pastan I:(2017)Paclitaxel synergizes with exposure time adjusted CD22-targeting immunotoxins against B-cell malignancies.Oncotarget. 2017;8(19): 30644-30655
Stein M, Dütting S, Mougiakakos D, Bösl M, Fritsch K, Reimer D, Urbanczyk S, Steinmetz T, Schuh W, Bozec A, Winkler TH, Jäck HM, Mielenz D:(2017)A defined metabolic state in pre B cells governs B-cell development and is counterbalanced by Swiprosin-2/EFhd1.Cell Death Differ. 2017;24(7): 1239-1252
Bach C, Steffen M, Roesler W, Winkler J, Mackensen A, Stachel KD, Metzler M, Spriewald BM:(2017)Systematic comparison of donor chimerism in peripheral blood and bone marrow after hematopoietic stem cell transplantation.Blood Cancer J. 2017;7(6): e566
Hönger G, Amico P, Arnold ML, Spriewald BM, Schaub S:(2017)Effects of weak/non-complement-binding HLA antibodies on C1q-binding.HLA. 2017;90(2): 88-94
Uebner M, Jacobi J, Schmidt D, Büttner-Herold M, Mackensen A, Spriewald BM:(2017)[Recent development of hypertension and acute renal failure in a 59-year-old woman].Internist (Berl). 2017;58(12): 1319-1323
Zecher D, Bach C, Staudner C, Böger CA, Bergler T, Banas B, Spriewald BM:(2017)Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen.Nephrol Dial Transplant. 2017;32(4): 730-737
Resheq YJ, Menzner AK, Bosch J, Tickle J, Li KK, Wilhelm A, Hepburn E, Murihead G, Ward ST, Curbishley SM, Zimmermann HW, Bruns T, Gilbert DF, Tripal P, Mackensen A, Adams DH, Weston CJ:(2017)Impaired Transmigration of Myeloid-Derived Suppressor Cells across Human Sinusoidal Endothelium Is Associated with Decreased Expression of CD13.J Immunol. 2017;199(5): 1672-1681
Moeckel J, Staiger N, Mackensen A, Meidenbauer N, Ullrich E:(2017)Sunitinib does not impair natural killer cell function in patients with renal cell carcinoma.Oncol Lett. 2017;14(1): 1089-1096
Middeke JM, Herbst R, Parmentier S, Bug G, Hänel M, Stuhler G, Schäfer-Eckart K, Rösler W, Klein S, Bethge W, Bitz U, Büttner B, Knoth H, Alakel N, Schaich M, Morgner A, Kramer M, Sockel K, von Bonin M, Stölzel F, Platzbecker U, Röllig C, Thiede C, Ehninger G, Bornhäuser M, Schetelig J:(2017)Long-Term Follow-Up and Impact of Comorbidity before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia-Lessons Learned from the Prospective BRIDGE Trial.Biol Blood Marrow Transplant. 2017;23(9): 1491-1497
Hutchinson JA, Riquelme P, Bach C, Kekarainen T, Fändrich F, Geissler EK, Ahrens N:(2017)Donor-specific Anti-HLA Antibodies Present in Pooled Human Serum Do Not Prevent Development of Human Mreg_UKR From Monocytes in Culture.Transplantation. 2017;101(5): e188-e190
Cursiefen C, Bock F, Clahsen T, Regenfuss B, Reis A, Steven P, Heindl LM, Bosch JJ, Hos D, Eming S, Grajewski R, Heiligenhaus A, Fauser S, Austin J, Langmann T:(2017)[New Therapeutic Approaches in Inflammatory Diseases of the Eye - Targeting Lymphangiogenesis and Cellular Immunity: Research Unit FOR 2240 Presents Itself].Klin Monatsbl Augenheilkd. 2017;234(5): 679-685
Heidrich K, Thiede C, Schäfer-Eckart K, Schmitz N, Aulitzky WE, Krämer A, Rösler W, Hänel M, Einsele H, Baldus CD, Trappe RU, Stölzel F, Middeke JM, Röllig C, Taube F, Krämer M, Serve H, Berdel WE, Ehninger G, Bornhäuser M, Schetelig J, Study Alliance Leukemia (SAL):(2017)Allogeneic hematopoietic cell transplantation in intermediate risk acute myeloid leukemia negative for FLT3-ITD, NPM1- or biallelic CEBPA mutations.Ann Oncol. 2017;28(11): 2793-2798
Hehlmann R, Lauseker M, Saußele S, Pfirrmann M, Krause S, Kolb HJ, Neubauer A, Hossfeld DK, Nerl C, Gratwohl A, Baerlocher GM, Heim D, Brümmendorf TH, Fabarius A, Haferlach C, Schlegelberger B, Müller MC, Jeromin S, Proetel U, Kohlbrenner K, Voskanyan A, Rinaldetti S, Seifarth W, Spieß B, Balleisen L, Goebeler MC, Hänel M, Ho A, Dengler J, Falge C, Kanz L, Kremers S, Burchert A, Kneba M, Stegelmann F, Köhne CA, Lindemann HW, Waller CF, Pfreundschuh M, Spiekermann K, Berdel WE, Müller L, Edinger M, Mayer J, Beelen DW, Bentz M, Link H, Hertenstein B, Fuchs R, Wernli M, Schlegel F, Schlag R, de Wit M, Trümper L, Hebart H, Hahn M, Thomalla J, Scheid C, Schafhausen P, Verbeek W, Eckart MJ, Gassmann W, Pezzutto A, Schenk M, Brossart P, Geer T, Bildat S, Schäfer E, Hochhaus A, Hasford J:(2017)Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants.Leukemia. 2017;31(11): 2398-2406
Tittlbach H, Schneider A, Strobel J, Zimmermann R, Maas S, Gebhardt B, Rauser G, Mach M, Mackensen A, Winkler TH, Winkler J:(2017)GMP-production of purified human B lymphocytes for the adoptive transfer in patients after allogeneic hematopoietic stem cell transplantation.J Transl Med. 2017;15(1): 228
Qorraj M, Böttcher M, Mougiakakos D:(2017)PD-L1/PD-1: new kid on the "immune metabolic" block.Oncotarget. 2017;8(43): 73364-73365
Ferreri AJM, Cwynarski K, Pulczynski E, Fox CP, Schorb E, La Rosée P, Binder M, Fabbri A, Torri V, Minacapelli E, Falautano M, Ilariucci F, Ambrosetti A, Roth A, Hemmaway C, Johnson P, Linton KM, Pukrop T, Sønderskov Gørløv J, Balzarotti M, Hess G, Keller U, Stilgenbauer S, Panse J, Tucci A, Orsucci L, Pisani F, Levis A, Krause SW, Schmoll HJ, Hertenstein B, Rummel M, Smith J, Pfreundschuh M, Cabras G, Angrilli F, Ponzoni M, Deckert M, Politi LS, Finke J, Reni M, Cavalli F, Zucca E, Illerhaus G, International Extranodal Lymphoma Study Group (IELSG):(2017)Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal LLancet Haematol. 2017;4(11): e510-e523
Krause SW, Oldenburg M, Hallek M, Neubauer A:(2017)[Priorities of German Oncologists. Results of the "choosing wisely" survey of the German Society of Hematology and Medical Oncology (DGHO)].Dtsch Med Wochenschr. 2017;142(18): e124-e130
Einsele H, Engelhardt M, Tapprich C, Müller J, Liebisch P, Langer C, Kropff M, Mügge LO, Jung W, Wolf HH, Metzner B, Hart C, Gramatzki M, Hertenstein B, Pfreundschuh M, Rösler W, Fischer T, Maschmeyer G, Kanz L, Hess G, Jäger E, Bentz M, Dürk HA, Salwender H, Hebart H, Straka C, Knop S:(2017)Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trial.Br J Haematol. 2017;179(4): 586-597
Steven A, Leisz S, Wickenhauser C, Schulz K, Mougiakakos D, Kiessling R, Denkert C, Seliger B:(2017)Linking CREB function with altered metabolism in murine fibroblast-based model cell lines.Oncotarget. 2017;8(57): 97439-97463
Bosch JJ, Heindl LM:(2017)[Novel Adjuvant Therapy for Ocular Melanoma].Klin Monatsbl Augenheilkd. 2017;234(5): 670-673
Iacobaeus E, Douagi I, Jitschin R, Andren AT, Gavin C, Lefsihane K, Davies L, Olsson T, Mougiakakos D, Kadri N, Le Blanc K:(2017)Functional shift of myeloid-derived suppressor cells during Multiple Sclerosis disease courseScand J Immunol. 2017;86(4): 335-335
Gocht A, Ensminger SM, Distler J, Spriewald B, Ramsperger-Gleixner M, Weyand M, Heim C:(2017)Tyrosine Kinase Inhibitor Nintedanib Reduces Development of Transplant Vasculopathy in a Murine Aortic Transplantation ModelJ Heart Lung Transplant. 2017;36(4): S370-S370

Publikationen 2017

Publikationen 2017

Notfall

Notfallinformationen UKER

Patienten & Besucher

Ärzte & Zuweiser

Forschung

Lehre